Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients aged 18-70 years~* Patients diagnosed with CKD (Estimated Glomerular Filtration Rate (eGFR) \>15 mL/min/1.73 m\*2) and hypertension without dialysis/replacement therapy~* Patients with uncontrolled hypertension (office SBP ≥140 mmHg and DBP ≥ 80 mmHg) who have received Renin-Angiotensin System Inhibitors (RASI) treatment or have not received RASI treatment because of any contraindications~* Patients who haven't received nifedipine GITS 60 mg (once per day) previously~* Patients for whom the decision to initiate treatment with nifedipine GITS 60 mg was made as per the investigator's routine treatment practice~* Signed informed consent~* No participation in an investigational program with interventions outside of routine clinical practice~Exclusion Criteria:~* Have a contraindication to nifedipine GITS according to the approved prescribing information~* Patients participating in an investigational program with interventions outside of routine clinical practice

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Nifedipine controlled-release tablets(Nifedipine GITS, ADALAT, BAYA1040) (Type: None): Male and female patients with a diagnosis of CKD and hypertension (age, 18-70 years) was enrolled.

Based on this trial design, predict the completion outcome and termination type (if applicable).